Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 131

Sort by

Sort Order Select

Journal Articles

Nonmyeloablative Allogeneic Transplantation (NMAT) Confers an Overall Survival Benefit with Similar Non-Relapse Mortality When Compared to Autologous Stem Transplantation (ASCT) for Patients (pts) with Relapsed Follicular Lymphoma (FL)

Blood (2019) 134 (Supplement_1): 322.

https://doi.org/10.1182/blood-2019-124590

Published: 2019

Journal Articles

The Impact of Different Mobilization Strategies in the Setting of Multiple Myeloma

Francesco Mazziotta, MD, Gabriele Buda, MD PhD, Nadia Cecconi, MD, Giulia Cervetti, MD, Lorenzo Iovino, MD, Enrico Orciuolo, MD PhD, Matteo Pelosini, MD PhD, Edoardo Benedetti, MD, Francesco Caracciolo, MD, Giovanni Carulli, MD, Sara Galimberti, MD PhD, Mario Petrini, MD PhD

Blood (2019) 134 (Supplement_1): 3254.

https://doi.org/10.1182/blood-2019-126118

Published: 2019

Journal Articles

Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell Transplantation

Blood (2019) 134 (Supplement_1): 2021.

https://doi.org/10.1182/blood-2019-126719

Published: 2019

Journal Articles

Modifications to the "Classical" Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Efficacy and Safety Study of a Less Toxic Approach Which Improves the Neurological Condition. a Mexican Perspective

Guillermo Jose Ruiz-Argüelles, Sr., MDFRCP. (GLASG) MACP, Juan Carlos Olivares Gazca, MD, Ivan Murrieta-Alvarez, MD, David Blumenkron-Marroquin, MD, Elias Eugenio Gonzalez-Lopez, MD, Alejandro Ruiz-Argüelles, MD, Guillermo Jose Ruiz-Delgado, Jr., MD, Andres Gomez De Leon, MD, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 3290.

https://doi.org/10.1182/blood.V130.Suppl_1.3290.3290

Published: 2017

Journal Articles

In the Era of Chemoimmunotherapy, Relapse Post Autologous Stem Cell Transplantation for Follicular Lymphoma Is Associated with Prolonged Overall Survival. an Analysis By the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Blood (2017) 130 (Supplement 1): 3299.

https://doi.org/10.1182/blood.V130.Suppl_1.3299.3299

Published: 2017

Journal Articles

Detection of Minimal Residual Disease in Autograft Is Prognostic of Survival Following Stem Cell Transplant in Multiple Myeloma

Michael P. Chu, MD, Eva Baigorri, Jitra Kriangkum, PhD, Joanne D. Hewitt, NP, PhD, Andrew Belch, Christopher P. Venner, Irwindeep Sandhu, MDFRCPC, Linda M. Pilarski, PhD

Blood (2017) 130 (Supplement 1): 1928.

https://doi.org/10.1182/blood.V130.Suppl_1.1928.1928

Published: 2017

Journal Articles

Prolonged Molecular and Clinical Remissions in Follicular Lymphoma Patients Treated with HDT/ASCT and Combination Immunotherapy with Rituximab and Interferon α

Liam Smyth, MD FRCPath, Rena Buckstein, MD FRCPC, Pennell Nancy, BSc, Rashmi Weerasinghe, Matthew Cheung, MD MS, FRCP, Eugenia Piliotis, MD FRCP, MD, Kevin Imrie, MD, David Spaner, MD PhD, Marciano D. Reis, MD, Lisa Chodirker, MD, Zeina Ghorab, Violet ruth,nancy Milliken, Angela Boudreau, RN, BScN, MN, CON(C), Neil Berinstein, MD

Blood (2017) 130 (Supplement 1): 4069.

https://doi.org/10.1182/blood.V130.Suppl_1.4069.4069

Published: 2017

Journal Articles

Cars in Leukemia: Relapse with Antigen-Negative Leukemia Originating from a Single B Cell Expressing the Leukemia-Targeting CAR

Blood (2016) 128 (22): 281.

https://doi.org/10.1182/blood.V128.22.281.281

Published: 2016

Journal Articles

Extended Duration of Anti-Thymocyte Globulin (ATG) Administration May Reduce the Risk of Graft-Versus-Host Disease in Patients with Aplastic Anemia Undergoing Matched-Related Allogeneic Peripheral Blood Stem Cell Transplantation

Laura A. Zider, MSN, ACNP-BC, RN, Amanda N. Seddon, PharmD, Sunita Nathan, MD, John J. Maciejewski, MD PhD, Jamile M. Shammo, MD, Gorgun Akpek, MD MHS

Blood (2016) 128 (22): 5876.

https://doi.org/10.1182/blood.V128.22.5876.5876

Published: 2016

Journal Articles

A Phase I Study of the Safety and Feasibility of Bortezomib in Combination with G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma

Armin Ghobadi, MD, Mark A Fiala, BS, CCRP, Geoffrey L. Uy, MD, Keith Stockerl-Goldstein, Ravi Vij, MD MBA, John F DiPersio, MD PhD

Blood (2016) 128 (22): 3381.

https://doi.org/10.1182/blood.V128.22.3381.3381

Published: 2016

Journal Articles

Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk Following Autologous Hematopoietic Cell Transplantation

Gabriel N. Mannis, MD, Thomas G. Martin, III, MD, Lloyd E. Damon, MD, Charalambos Andreadis, MD MSCE, Rebecca L. Olin, MD MSCE, Katie Kong, Malek Faham, MD PhD, Weiyun Z. Ai, MD PhD, Karin ML Gaensler, MD, Peter H. Sayre, MD PhD, Jeffrey L. Wolf, MD PhD, Aaron C. Logan, MD PhD

Blood (2015) 126 (23): 1420.

https://doi.org/10.1182/blood.V126.23.1420.1420

Published: 2015

Journal Articles

In-Vivo Purging with Rituximab (R) Followed By Z/BEAM Vs BEAM/R Autologous Stem Cell Conditioning for Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) Patients (pts): Mature Results from a Combined Analysis of 3 Trials

Blood (2015) 126 (23): 3192.

https://doi.org/10.1182/blood.V126.23.3192.3192

Published: 2015

Journal Articles

The EBMT Lymphoma Working Party-European Mantle Cell Lymphoma Network Consensus Project On The Role Of Autologous and Allogeneic Stem Cell Transplantation In Mantle Cell Lymphoma: Recommendations Applying The Delphi Procedure

Stephen Paul Robinson, MBBS, MRCP, FRCPath, PhD, Paolo Corradini, Peter Dreger, MD, Dolores Caballero, MD, PhD, Christian H Geisler, Michele Ghielmini, MD, Steven Le Gouill, MD, PhD, Eva Kimby, MD, Simon Rule, MD, Umberto Vitolo, Martin Dreyling, O. Hermine, MD, PhD

Blood (2013) 122 (21): 3405.

https://doi.org/10.1182/blood.V122.21.3405.3405

Published: 2013

Journal Articles

Targeting CD96 For Antibody Based Elimination Of Leukemic Stem Cells In AML: A New Strategy In Stem Cell Transplantation

Matthias Staudinger, PhD, Christian Kellner, PhD, Matthias Peipp, PhD, Natalie Schub, MD, Andreas Humpe, MD, Martin Gramatzki, MD

Blood (2013) 122 (21): 3972.

https://doi.org/10.1182/blood.V122.21.3972.3972

Published: 2013

Journal Articles

Haploidentical Stem Cell Transplantation After Negative Depletion Of T Cells Expressing The αβ Chain Of The T-Cell Receptor (TCR) For Adults With Hematological Malignancies

Lucia Prezioso, MD, Sabrina Bonomini, PhD, Chiara Lambertini, Chiara Schifano, Elena Rossetti, MD, Alessandro Monti, Giannalisa Todaro, Gabriella Sammarelli, PhD, Maria Sassi, Luisa Craviotto, MD, Elena Masselli, MD, Cecilia Caramatti, MD, Franco Aversa, MD

Blood (2013) 122 (21): 4609.

https://doi.org/10.1182/blood.V122.21.4609.4609

Published: 2013

Journal Articles

Tracking T Cell Dynamics In The First Month After Haplo-HSCT With Post-Transplant Cyclophosphamide Reveals a Predominant Contribution Of Memory Stem T Cells To The Early Phase Of Immune Reconstitution

Nicoletta Cieri, MD, Jacopo Peccatori, MD, Giacomo Oliveira, MSc, Raffaella Greco, MD, Sarah Marktel, MD, Francesca Lunghi, MD, Fabio Ciceri, MD, Chiara Bonini, MD

Blood (2013) 122 (21): 4615.

https://doi.org/10.1182/blood.V122.21.4615.4615

Published: 2013

Journal Articles

Long-Term Follow-up of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML): A Survey of 3567 Patients From the Acute Leukemia Working Party of the EBMT.

Tomasz Czerw, MD, Myriam Labopin, Norbert C. Gorin, MD, PhD, Sebastian Giebel, MD, Didier Blaise, MD, Giovanna Meloni, MD, Arnaud Pigneux, MD, PhD, Alberto Bosi, MD, Hendrik Veelken, MD PhD, Felicetto Ferrara, MD, Nicolaas Schaap, MD, PhD, Michele Baccarani, MD, Mohamad Mohty

Blood (2012) 120 (21): 3112.

https://doi.org/10.1182/blood.V120.21.3112.3112

Published: 2012

Journal Articles

Higher Percentage of CD34 + CD38 − Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predict Unsustained Complete Remission in AML

Adriana Plesa, MD, Mohamed Elhamri, PhD, Gilles Clapisson, Eve Mattei, Sophie Gazzo, PhD, Olivier Hequet, MD, Mauricette Michallet, MD, PhD, Charles Dumontet, MD, PhD, Xavier Thomas, MD

Blood (2012) 120 (21): 1485.

https://doi.org/10.1182/blood.V120.21.1485.1485

Published: 2012

Journal Articles

Intensive Induction, Autologous Stem Cell Transplantation and Rituximab Maintenance Has Changed Event Free Survival and Overall Survival in Mantle Cell Lymphoma Patients. Using Gemcitabine and Oxaliplatin in First Line Therapy

Vladimir I. Vorobyev, MD, Yuri Yu. Lorie, MD, PhD, Evgenii' E. Zvonkov, MD, PhD, Eduard G. Gemdjian, PhD, Aminat U. Magomedova, MD, PhD, Anait L. Melikyan, MD, PhD, Jana K. Mangasarova, MD, PhD, Elena O. Gribanova, MD, PhD, Vera A. Zherebtsova, MD, PhD, Sergey K. Kravchenko, MD, PhD, Valeri G. Savchenko, MD, PhD

Blood (2012) 120 (21): 2034.

https://doi.org/10.1182/blood.V120.21.2034.2034

Published: 2012

Journal Articles

Development of an Inducible Caspase-9 Safety Switch for Pluripotent Stem Cell Based Therapies

Chuanfeng Wu, PhD, So Gun Hong, PhD, Alexander Jares, Vicky Guo, Thomas Winkler, MD, Cynthia E. Dunbar, MD

Blood (2012) 120 (21): 2047.

https://doi.org/10.1182/blood.V120.21.2047.2047

Published: 2012

NARROW

Nonmyeloablative Allogeneic Transplantation (NMAT) Confers an Overall Survival Benefit with Similar Non-Relapse Mortality When Compared to Autologous Stem Transplantation (ASCT) for Patients (pts) with Relapsed Follicular Lymphoma (FL)

The Impact of Different Mobilization Strategies in the Setting of Multiple Myeloma

Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell Transplantation

Modifications to the "Classical" Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Efficacy and Safety Study of a Less Toxic Approach Which Improves the Neurological Condition. a Mexican Perspective

In the Era of Chemoimmunotherapy, Relapse Post Autologous Stem Cell Transplantation for Follicular Lymphoma Is Associated with Prolonged Overall Survival. an Analysis By the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Detection of Minimal Residual Disease in Autograft Is Prognostic of Survival Following Stem Cell Transplant in Multiple Myeloma

Prolonged Molecular and Clinical Remissions in Follicular Lymphoma Patients Treated with HDT/ASCT and Combination Immunotherapy with Rituximab and Interferon α

Cars in Leukemia: Relapse with Antigen-Negative Leukemia Originating from a Single B Cell Expressing the Leukemia-Targeting CAR

Extended Duration of Anti-Thymocyte Globulin (ATG) Administration May Reduce the Risk of Graft-Versus-Host Disease in Patients with Aplastic Anemia Undergoing Matched-Related Allogeneic Peripheral Blood Stem Cell Transplantation

A Phase I Study of the Safety and Feasibility of Bortezomib in Combination with G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma

Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk Following Autologous Hematopoietic Cell Transplantation

In-Vivo Purging with Rituximab (R) Followed By Z/BEAM Vs BEAM/R Autologous Stem Cell Conditioning for Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) Patients (pts): Mature Results from a Combined Analysis of 3 Trials

The EBMT Lymphoma Working Party-European Mantle Cell Lymphoma Network Consensus Project On The Role Of Autologous and Allogeneic Stem Cell Transplantation In Mantle Cell Lymphoma: Recommendations Applying The Delphi Procedure

Targeting CD96 For Antibody Based Elimination Of Leukemic Stem Cells In AML: A New Strategy In Stem Cell Transplantation

Haploidentical Stem Cell Transplantation After Negative Depletion Of T Cells Expressing The αβ Chain Of The T-Cell Receptor (TCR) For Adults With Hematological Malignancies

Tracking T Cell Dynamics In The First Month After Haplo-HSCT With Post-Transplant Cyclophosphamide Reveals a Predominant Contribution Of Memory Stem T Cells To The Early Phase Of Immune Reconstitution

Long-Term Follow-up of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML): A Survey of 3567 Patients From the Acute Leukemia Working Party of the EBMT.

Higher Percentage of CD34 + CD38 − Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predict Unsustained Complete Remission in AML

Intensive Induction, Autologous Stem Cell Transplantation and Rituximab Maintenance Has Changed Event Free Survival and Overall Survival in Mantle Cell Lymphoma Patients. Using Gemcitabine and Oxaliplatin in First Line Therapy

Development of an Inducible Caspase-9 Safety Switch for Pluripotent Stem Cell Based Therapies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only